UPDATE: Stifel Nicolaus Raises PT to $30 on Team Health Holdings on Outlook
Stifel Nicolaus reiterated its Buy rating on Team Health Holdings (NYSE: TMH) and raised its price target from $29 to $30.
Stifel Nicolaus commented, "Team stands to benefit from healthcare reform in two ways. Raising Medicaid payments to physicians for primary care services to the level of Medicare in 2013-14 will boost revenues for Team's emergency department services, and expansion of insurance coverage to the uninsured scheduled to begin in 2014 will reduce the number of low- or no-pay uninsured patients treated in Team's emergency departments. We believe that Team's continued strong fundamental performance illustrates that health reform is a not a prerequisite for share price appreciation. Our earnings model, target price, and Buy rating all assume no health reform benefit."
Team Health Holdings closed at $26.61 on Wednesday.
Latest Ratings for TMH
|Sep 2016||Citigroup||Initiates Coverage on||Neutral|
|Aug 2016||JP Morgan||Maintains||Neutral|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.